Erratum to: Beta cell connectivity in pancreatic islets: a type 2 diabetes target? (Cellular and Molecular Life Sciences, (2015), 72, 3, (453-467), 10.1007/s00018-014-1755-4);Beta cell connectivity in pancreatic islets: A type 2 diabetes target?

Cellular and Molecular Life Sciences

Volumn 72, Issue 3, 2015, Pages 453-467

  Rutter, Guy A ^a   Hodson, David J ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Diabetes; Human; Imaging; Insulin; Mouse; Network; Signaling

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CONNEXIN 36; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN; INSULIN; MEMBRANE PROTEIN; TRANSCRIPTION FACTOR 7 LIKE 2; UNCLASSIFIED DRUG; ZINC TRANSPORTER 8 PROTEIN;

ADCY5 GENE; ALLELE; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL COMMUNICATION; CELL FUNCTION; CELL METABOLISM; ENVIRONMENTAL FACTOR; EUKARYOTIC FLAGELLUM; EXOCYTOSIS; GAP JUNCTION; GENE; GENETIC ASSOCIATION; GLUCOSE INTOLERANCE; HEREDITY; HUMAN; INSULIN RELEASE; INTRACELLULAR SIGNALING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PARACRINE SIGNALING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SLC30A8 GENE; SYMPATHETIC NERVE CELL; TCFL72 GENE; WNT SIGNALING PATHWAY; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; INNERVATION; METABOLISM; PANCREAS ISLET; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION (PROCESS);

ANIMALS; CELL COMMUNICATION; DIABETES MELLITUS, TYPE 2; GAP JUNCTIONS; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MODELS, BIOLOGICAL; PARACRINE COMMUNICATION;

EID: 84921376871     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-018-2767-2     Document Type: Erratum

References (165)

1. International Diabetes Federation (2013) IDF Diabetes Atlas, 6th edn. International Diabetes Federation, Brussels, Belgium
2. Currie CJ, Poole CD, Gale EA (2009) The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52(9):1766-1777. doi: 10.1007/s00125-009-1440-6
3. Stitt AW (2010) AGEs and diabetic retinopathy. Invest Ophthalmol Vis Sci 51(10):4867-4874. doi: 10.1167/iovs.10-5881
4. van de Bunt M, Gloyn AL (2012) A tale of two glucose transporters: how GLUT2 re-emerged as a contender for glucose transport into the human beta cell. Diabetologia 55(9):2312-2315. doi: 10.1007/s00125-012-2612-3
5. Iynedjian PB (1993) Mammalian glucokinase and its gene. Biochem J 293(Pt 1):1-13
6. Prentki M, Matschinsky FM, Madiraju SR (2013) Metabolic signaling in fuel-induced insulin secretion. Cell Metab 18(2):162-185. doi: 10.1016/j.cmet.2013.05.018
7. Rutter GA (2001) Nutrient-secretion coupling in the pancreatic islet beta-cell: recent advances. Mol Aspects Med 22(6):247-284
8. 2+ uniporter MCU is essential for glucose-induced ATP increases in pancreatic beta-cells. PLoS ONE 7(7):e39722. doi: 10.1371/journal.pone.0039722
9. Kennedy HJ, Pouli AE, Ainscow EK, Jouaville LS, Rizzuto R, Rutter GA (1999) Glucose generates sub-plasma membrane ATP microdomains in single islet beta-cells. Potential role for strategically located mitochondria. J Biol Chem 274(19):13281-13291
10. Ashcroft FM, Harrison DE, Ashcroft SJ (1984) Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells. Nature 312(5993):446-448
11. + channels and insulin secretion: their role in health and disease. Diabetologia 42(8):903-919. doi: 10.1007/s001250051247
12. Ammala C, Ashcroft FM, Rorsman P (1993) Calcium-independent potentiation of insulin release by cyclic AMP in single beta-cells. Nature 363(6427):356-358. doi: 10.1038/363356a0
13. Henquin JC (2000) Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49(11):1751-1760
14. 2+ microdomains and the control of insulin secretion. Cell Calcium 40(5-6):539-551. doi: 10.1016/j.ceca.2006.08.015
15. 2+ concentration changes at the secretory vesicle surface with a recombinant targeted cameleon. Curr Biol 9(16):915-918
16. Tsuboi T, Rutter GA (2003) Multiple forms of "kiss-and-run" exocytosis revealed by evanescent wave microscopy. Curr Biol 13(7):563-567
17. Rutter GA, Varadi A, Tsuboi T, Parton L, Ravier M (2006) Insulin secretion in health and disease: genomics, proteomics and single vesicle dynamics. Biochem Soc Trans 34(Pt 2):247-250. doi: 10.1042/BST20060247
18. Serre-Beinier V, Mas C, Calabrese A, Caton D, Bauquis J, Caille D, Charollais A, Cirulli V, Meda P (2002) Connexins and secretion. Biol Cell 94(7-8):477-492 S0248490002000242
19. Bavamian S, Klee P, Britan A, Populaire C, Caille D, Cancela J, Charollais A, Meda P (2007) Islet-cell-to-cell communication as basis for normal insulin secretion. Diabetes Obes Metab 9(Suppl 2):118-132. doi: 10.1111/j.1463-1326.2007.00780.x
20. Bosco D, Haefliger JA, Meda P (2011) Connexins: key mediators of endocrine function. Physiol Rev 91(4):1393-1445. doi: 10.1152/physrev.00027.2010
21. Meda P (2013) Protein-mediated interactions of pancreatic islet cells. Scientifica (Cairo) 2013:621249. doi: 10.1155/2013/621249
22. Farnsworth NL, Benninger RK (2014) New insights into the role of connexins in pancreatic islet function and diabetes. FEBS Lett 588(8):1278-1287. doi: 10.1016/j.febslet.2014.02.035
23. Salomon D, Meda P (1986) Heterogeneity and contact-dependent regulation of hormone secretion by individual B cells. Exp Cell Res 162(2):507-520
24. Caton D, Calabrese A, Mas C, Serre-Beinier V, Wonkam A, Meda P (2002) Beta-cell crosstalk: a further dimension in the stimulus-secretion coupling of glucose-induced insulin release. Diabetes Metab 28(6 Pt 2):3S45-3S53 discussion 43S108-112
25. Steiner DJ, Kim A, Miller K, Hara M (2010) Pancreatic islet plasticity: interspecies comparison of islet architecture and composition. Islets 2(3):135-145
26. Hodson DJ, Mitchell RK, Marselli L, Pullen TJ, Brias SG, Semplici F, Everett KL, Cooper DM, Bugliani M, Marchetti P, Lavallard V, Bosco D, Piemonti L, Johnson PR, Hughes SJ, Li D, Li WH, Shapiro AM, Rutter GA (2014) ADCY5 couples glucose to insulin secretion in human islets. Diabetes. doi: 10.2337/db13-1607
27. Hodson DJ, Mitchell RK, Bellomo EA, Sun G, Vinet L, Meda P, Li D, Li WH, Bugliani M, Marchetti P, Bosco D, Piemonti L, Johnson P, Hughes SJ, Rutter GA (2013) Lipotoxicity disrupts incretin-regulated human beta cell connectivity. J Clin Invest 123(10):4182-4194. doi: 10.1172/JCI68459
28. Rutter GA, Hodson DJ (2013) Minireview: intraislet regulation of insulin secretion in humans. Mol Endocrinol 27(12):1984-1995. doi: 10.1210/me.2013-1278
29. Stozer A, Gosak M, Dolensek J, Perc M, Marhl M, Rupnik MS, Korosak D (2013) Functional connectivity in islets of Langerhans from mouse pancreas tissue slices. PLoS Comput Biol 9(2):e1002923. doi: 10.1371/journal.pcbi.1002923
30. Stozer A, Dolensek J, Rupnik MS (2013) Glucose-stimulated calcium dynamics in islets of Langerhans in acute mouse pancreas tissue slices. PLoS ONE 8(1):e54638. doi: 10.1371/journal.pone.0054638
31. Benninger RK, Piston DW (2014) Cellular communication and heterogeneity in pancreatic islet insulin secretion dynamics. Trends Endocrinol Metab. doi: 10.1016/j.tem.2014.02.005
32. Orci L, Unger RH (1975) Functional subdivision of islets of Langerhans and possible role of D cells. Lancet 2(7947):1243-1244
33. Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A (2006) The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci USA 103(7):2334-2339. doi: 10.1073/pnas.0510790103
34. Nyman LR, Wells KS, Head WS, McCaughey M, Ford E, Brissova M, Piston DW, Powers AC (2008) Real-time, multidimensional in vivo imaging used to investigate blood flow in mouse pancreatic islets. J Clin Invest 118(11):3790-3797. doi: 10.1172/JCI36209
35. Cleaver O, Dor Y (2012) Vascular instruction of pancreas development. Development 139(16):2833-2843. doi: 10.1242/dev.065953
36. Brissova M, Fowler MJ, Nicholson WE, Chu A, Hirshberg B, Harlan DM, Powers AC (2005) Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem 53(9):1087-1097. doi: 10.1369/jhc.5C6684.2005
37. Bosco D, Armanet M, Morel P, Niclauss N, Sgroi A, Muller YD, Giovannoni L, Parnaud G, Berney T (2010) Unique arrangement of alpha- and beta-cells in human islets of Langerhans. Diabetes 59(5):1202-1210. doi: 10.2337/db09-1177
38. Kilimnik G, Zhao B, Jo J, Periwal V, Witkowski P, Misawa R, Hara M (2011) Altered islet composition and disproportionate loss of large islets in patients with type 2 diabetes. PLoS ONE 6(11):e27445. doi: 10.1371/journal.pone.0027445
39. Halban PA, Wollheim CB, Blondel B, Meda P, Niesor EN, Mintz DH (1982) The possible importance of contact between pancreatic islet cells for the control of insulin release. Endocrinology 111(1):86-94. doi: 10.1210/endo-111-1-86
40. 2+ and insulin secretory responses of MIN6 pseudoislets. Diabetes 48(7):1402-1408
41. 2+)-signals within insulin-secreting pseudoislets: effects of gap-junctional uncouplers. Cell Calcium 27(5):287-296. doi: 10.1054/ceca.2000.0117
42. Hodson DJ, Molino F, Fontanaud P, Bonnefont X, Mollard P (2010) Investigating and Modelling Pituitary Endocrine Network Function. J Neuroendocrinol 22:1217-1225. doi: 10.1111/j.1365-2826.2010.02052.x
43. Takahashi N, Kishimoto T, Nemoto T, Kadowaki T, Kasai H (2002) Fusion pore dynamics and insulin granule exocytosis in the pancreatic islet. Science 297(5585):1349-1352. doi: 10.1126/science.1073806
44. Li D, Chen S, Bellomo EA, Tarasov AI, Kaut C, Rutter GA, Li WH (2011) Imaging dynamic insulin release using a fluorescent zinc indicator for monitoring induced exocytotic release (ZIMIR). Proc Natl Acad Sci USA 108(52):21063-21068. doi: 10.1073/pnas.1109773109
45. Low JT, Mitchell JM, Do OH, Bax J, Rawlings A, Zavortink M, Morgan G, Parton RG, Gaisano HY, Thorn P (2013) Glucose principally regulates insulin secretion in mouse islets by controlling the numbers of granule fusion events per cell. Diabetologia 56(12):2629-2637. doi: 10.1007/s00125-013-3019-5
46. 2+: a diversity oriented modular "click-SNAr-click" approach. Chem Sci. doi: 10.1039/c4sc01249f
47. Akemann W, Mutoh H, Perron A, Rossier J, Knopfel T (2010) Imaging brain electric signals with genetically targeted voltage-sensitive fluorescent proteins. Nat Methods 7(8):643-649. doi: 10.1038/nmeth.1479
48. Hodson DJ, Romano N, Schaeffer M, Fontanaud P, Lafont C, Fiordelisio T, Mollard P (2012) Coordination of calcium signals by pituitary endocrine cells in situ. Cell Calcium 51(3-4):222-230. doi: 10.1016/j.ceca.2011.11.007
49. Dolensek J, Stozer A, Skelin Klemen M, Miller EW, Slak Rupnik M (2013) The relationship between membrane potential and calcium dynamics in glucose-stimulated beta cell syncytium in acute mouse pancreas tissue slices. PLoS ONE 8(12):e82374. doi: 10.1371/journal.pone.0082374
50. 2+ in pituitary cells due to action potentials. Nature 329(6141):719-721. doi: 10.1038/329719a0
51. Peterlin ZA, Kozloski J, Mao BQ, Tsiola A, Yuste R (2000) Optical probing of neuronal circuits with calcium indicators. Proc Natl Acad Sci USA 97(7):3619-3624
52. Cossart R, Ikegaya Y, Yuste R (2005) Calcium imaging of cortical networks dynamics. Cell Calcium 37(5):451-457. doi: 10.1016/j.ceca.2005.01.013
53. Ikegaya Y, Le Bon-Jego M, Yuste R (2005) Large-scale imaging of cortical network activity with calcium indicators. Neurosci Res 52(2):132-138. doi: 10.1016/j.neures.2005.02.004
54. Hodson DJ, Schaeffer M, Romano N, Fontanaud P, Lafont C, Birkenstock J, Molino F, Christian H, Lockey J, Carmignac D, Fernandez-Fuente M, Le Tissier P, Mollard P (2012) Existence of long-lasting experience-dependent plasticity in endocrine cell networks. Nature Commun 3:605. doi: 10.1038/ncomms1612
55. Hodson DJ, Tarasov AI, Gimeno Brias S, Mitchell RK, Johnston NR, Haghollahi S, Cane MC, Bugliani M, Marchetti P, Bosco D, Johnson PR, Hughes SJ, Rutter GA (2014) Incretin-modulated beta cell energetics in intact islets of Langerhans. Mol Endocrinol 28(6):860-871. doi: 10.1210/me.2014-1038
56. Alon U (2007) Network motifs: theory and experimental approaches. Nat Rev Genet 8(6):450-461. doi: 10.1038/nrg2102
57. Bullmore E, Sporns O (2009) Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci 10(3):186-198. doi: 10.1038/nrn2575
58. Price DJ (1965) Networks of Scientific Papers. Science 149:510-515
59. Barabasi AL, Albert R (1999) Emergence of scaling in random networks. Science 286(5439):509-512
60. Barabasi AL (2009) Scale-free networks: a decade and beyond. Science 325(5939):412-413. doi: 10.1126/science.1173299
61. Bonifazi P, Goldin M, Picardo MA, Jorquera I, Cattani A, Bianconi G, Represa A, Ben-Ari Y, Cossart R (2009) GABAergic hub neurons orchestrate synchrony in developing hippocampal networks. Science 326(5958):1419-1424. doi: 10.1126/science.1175509
62. Mollard P, Hodson DJ, Lafont C, Rizzoti K, Drouin J (2012) A tridimensional view of pituitary development and function. Trends Endocrinol Metab. doi: 10.1016/j.tem.2012.02.004
63. Le Tissier PR, Hodson DJ, Lafont C, Fontanaud P, Schaeffer M, Mollard P (2012) Anterior pituitary cell networks. Front Neuroendocrinol 33(3):252-266. doi: 10.1016/j.yfrne.2012.08.002
64. Caicedo A (2013) Paracrine and autocrine interactions in the human islet: more than meets the eye. Semin Cell Dev Biol 24(1):11-21. doi: 10.1016/j.semcdb.2012.09.007
65. Serre-Beinier V, Le Gurun S, Belluardo N, Trovato-Salinaro A, Charollais A, Haefliger JA, Condorelli DF, Meda P (2000) Cx36 preferentially connects beta-cells within pancreatic islets. Diabetes 49(5):727-734
66. Condorelli DF, Belluardo N, Trovato-Salinaro A, Mudo G (2000) Expression of Cx36 in mammalian neurons. Brain Res Brain Res Rev 32(1):72-85 S0165017399000685
67. Charpantier E, Cancela J, Meda P (2007) Beta cells preferentially exchange cationic molecules via connexin 36 gap junction channels. Diabetologia 50(11):2332-2341. doi: 10.1007/s00125-007-0807-9
68. 2+ and insulin oscillations, and basal insulin release. Diabetes 54(6):1798-1807
69. Speier S, Gjinovci A, Charollais A, Meda P, Rupnik M (2007) Cx36-mediated coupling reduces beta-cell heterogeneity, confines the stimulating glucose concentration range, and affects insulin release kinetics. Diabetes 56(4):1078-1086. doi: 10.2337/db06-0232
70. ATP channel activity for regulated insulin secretion. PLoS Biol 4(2):e26 05-PLBI-RA-0819R2
71. Head WS, Orseth ML, Nunemaker CS, Satin LS, Piston DW, Benninger RK (2012) Connexin-36 gap junctions regulate in vivo first- and second-phase insulin secretion dynamics and glucose tolerance in the conscious mouse. Diabetes 61(7):1700-1707. doi: 10.2337/db11-1312
72. Serre-Beinier V, Bosco D, Zulianello L, Charollais A, Caille D, Charpantier E, Gauthier BR, Diaferia GR, Giepmans BN, Lupi R, Marchetti P, Deng S, Buhler L, Berney T, Cirulli V, Meda P (2009) Cx36 makes channels coupling human pancreatic beta-cells, and correlates with insulin expression. Hum Mol Genet 18(3):428-439. doi: 10.1093/hmg/ddn370
73. Farnsworth NL, Hemmati A, Pozzoli M, Benninger RK (2014) Fluorescence recovery after photobleaching reveals regulation and distribution of Cx36 gap junction coupling within mouse islets of langerhans. J Physiol. doi: 10.1113/jphysiol.2014.276733
74. Ahren B (2000) Autonomic regulation of islet hormone secretion-implications for health and disease. Diabetologia 43(4):393-410. doi: 10.1007/s001250051322
75. Zhang M, Fendler B, Peercy B, Goel P, Bertram R, Sherman A, Satin L (2008) Long lasting synchronization of calcium oscillations by cholinergic stimulation in isolated pancreatic islets. Biophys J 95(10):4676-4688. doi: 10.1529/biophysj.107.125088
76. Fendler B, Zhang M, Satin L, Bertram R (2009) Synchronization of pancreatic islet oscillations by intrapancreatic ganglia: a modeling study. Biophys J 97(3):722-729. doi: 10.1016/j.bpj.2009.05.016
77. Ahren B, Holst JJ (2001) The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia. Diabetes 50(5):1030-1038
78. Filipsson K, Kvist-Reimer M, Ahren B (2001) The neuropeptide pituitary adenylate cyclase-activating polypeptide and islet function. Diabetes 50(9):1959-1969
79. Kurose T, Seino Y, Nishi S, Tsuji K, Taminato T, Tsuda K, Imura H (1990) Mechanism of sympathetic neural regulation of insulin, somatostatin, and glucagon secretion. Am J Physiol 258(1 Pt 1):E220-E227
80. 2+ concentration. J Biol Chem 263(4):1855-1860
81. Kuo WN, Hodgins DS, Kuo JF (1973) Adenylate cyclase in islets of Langerhans. Isolation of islets and regulation of adenylate cyclase activity by various hormones and agents. J Biol Chem 248(8):2705-2711
82. Asensio C, Jimenez M, Kuhne F, Rohner-Jeanrenaud F, Muzzin P (2005) The lack of beta-adrenoceptors results in enhanced insulin sensitivity in mice exhibiting increased adiposity and glucose intolerance. Diabetes 54(12):3490-3495
83. Rodriguez-Diaz R, Abdulreda MH, Formoso AL, Gans I, Ricordi C, Berggren PO, Caicedo A (2011) Innervation patterns of autonomic axons in the human endocrine pancreas. Cell Metab 14(1):45-54. doi: 10.1016/j.cmet.2011.05.008
84. Rodriguez-Diaz R, Dando R, Jacques-Silva MC, Fachado A, Molina J, Abdulreda MH, Ricordi C, Roper SD, Berggren PO, Caicedo A (2011) Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming beta cell function in humans. Nat Med 17(7):888-892. doi: 10.1038/nm.2371
85. Molina J, Rodriguez-Diaz R, Fachado A, Jacques-Silva MC, Berggren PO, Caicedo A (2014) control of insulin secretion by cholinergic signaling in the human pancreatic islet. Diabetes. doi: 10.2337/db13-1371
86. 2+]i oscillations in single human pancreatic islets. Cell Calcium 20(5):409-414
87. diIorio P, Rittenhouse AR, Bortell R, Jurczyk A (2014) Role of cilia in normal pancreas function and in diseased states. Birth Defects Res C Embryo Today 102(2):126-138. doi: 10.1002/bdrc.21064
88. Oh EC, Katsanis N (2012) Cilia in vertebrate development and disease. Development 139(3):443-448. doi: 10.1242/dev.050054
89. Cano DA, Sekine S, Hebrok M (2006) Primary cilia deletion in pancreatic epithelial cells results in cyst formation and pancreatitis. Gastroenterology 131(6):1856-1869. doi: 10.1053/j.gastro.2006.10.050
90. Ait-Lounis A, Baas D, Barras E, Benadiba C, Charollais A, Nlend Nlend R, Liegeois D, Meda P, Durand B, Reith W (2007) Novel function of the ciliogenic transcription factor RFX3 in development of the endocrine pancreas. Diabetes 56(4):950-959. doi: 10.2337/db06-1187
91. Granot Z, Swisa A, Magenheim J, Stolovich-Rain M, Fujimoto W, Manduchi E, Miki T, Lennerz JK, Stoeckert CJ Jr, Meyuhas O, Seino S, Permutt MA, Piwnica-Worms H, Bardeesy N, Dor Y (2009) LKB1 regulates pancreatic beta cell size, polarity, and function. Cell Metab 10(4):296-308. doi: 10.1016/j.cmet.2009.08.010
92. Green JA, Mykytyn K (2014) Neuronal primary cilia: an underappreciated signaling and sensory organelle in the brain. Neuropsychopharmacology 39(1):244-245. doi: 10.1038/npp.2013.203
93. Wang J, Silva M, Haas LA, Morsci NS, Nguyen KC, Hall DH, Barr MM (2014) C. elegans ciliated sensory neurons release extracellular vesicles that function in animal communication. Curr Biol 24(5):519-525. doi: 10.1016/j.cub.2014.01.002
94. Yang YH, Szabat M, Bragagnini C, Kott K, Helgason CD, Hoffman BG, Johnson JD (2011) Paracrine signalling loops in adult human and mouse pancreatic islets: netrins modulate beta cell apoptosis signalling via dependence receptors. Diabetologia 54(4):828-842. doi: 10.1007/s00125-010-2012-5
95. ATP conductance in mouse pancreatic islets provide support for electrical bursting driven by metabolic oscillations. Am J Physiol Endocrinol Metab 305(7):E805-E817. doi: 10.1152/ajpendo.00046.2013
96. 2+ oscillations. Biophys J 99(1):76-84. doi: 10.1016/j.bpj.2010.04.012
97. Nunemaker CS, Satin LS (2004) Comparison of metabolic oscillations from mouse pancreatic beta cells and islets. Endocrine 25(1):61-67. doi: 10.1385/ENDO:25:1:61
98. 2+). Diabetologia 56(7):1577-1586. doi: 10.1007/s00125-013-2894-0
99. Bennett BD, Jetton TL, Ying G, Magnuson MA, Piston DW (1996) Quantitative subcellular imaging of glucose metabolism within intact pancreatic islets. J Biol Chem 271(7):3647-3651
100. Piston DW, Knobel SM (1999) Quantitative imaging of metabolism by two-photon excitation microscopy. Methods Enzymol 307:351-368
101. 2+](i) and insulin rhythms in mouse islets. PLoS ONE 4(12):e8428. doi: 10.1371/journal.pone.0008428
102. Kohen E, Kohen C, Thorell B, Mintz DH, Rabinovitch A (1979) Intercellular communication in pancreatic islet monolayer cultures: a microfluorometric study. Science 204(4395):862-865
103. Meda P, Amherdt M, Perrelet A, Orci L (1981) Metabolic coupling between cultured pancreatic b-cells. Exp Cell Res 133(2):421-430
104. Reimann F, Gribble FM (2002) Glucose-sensing in glucagon-like peptide-1-secreting cells. Diabetes 51(9):2757-2763
105. Tolhurst G, Reimann F, Gribble FM (2009) Nutritional regulation of glucagon-like peptide-1 secretion. J Physiol 587(Pt 1):27-32. doi: 10.1113/jphysiol.2008.164012
106. Parker HE, Wallis K, le Roux CW, Wong KY, Reimann F, Gribble FM (2012) Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion. Br J Pharmacol 165(2):414-423. doi: 10.1111/j.1476-5381.2011.01561.x
107. 2+ influx through L-type voltage-gated calcium channels mediate Raf-independent activation of extracellular regulated kinase in response to glucagon-like peptide-1 in pancreatic beta-cells. J Biol Chem 277(50):48146-48151. doi: 10.1074/jbc.M209165200
108. Leech CA, Dzhura I, Chepurny OG, Kang G, Schwede F, Genieser HG, Holz GG (2011) Molecular physiology of glucagon-like peptide-1 insulin secretagogue action in pancreatic beta cells. Prog Biophys Mol Biol 107(2):236-247. doi: 10.1016/j.pbiomolbio.2011.07.005
109. Ravier MA, Leduc M, Richard J, Linck N, Varrault A, Pirot N, Roussel MM, Bockaert J, Dalle S, Bertrand G (2013) beta-Arrestin2 plays a key role in the modulation of the pancreatic beta cell mass in mice. Diabetologia. doi: 10.1007/s00125-013-3130-7
110. 2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells. Biochem J 369(Pt 2):287-299. doi: 10.1042/BJ20021288
111. Peyot ML, Gray JP, Lamontagne J, Smith PJ, Holz GG, Madiraju SR, Prentki M, Heart E (2009) Glucagon-like peptide-1 induced signaling and insulin secretion do not drive fuel and energy metabolism in primary rodent pancreatic beta-cells. PLoS ONE 4(7):e6221. doi: 10.1371/journal.pone.0006221
112. Berg J, Hung YP, Yellen G (2009) A genetically encoded fluorescent reporter of ATP:ADP ratio. Nat Methods 6(2):161-166. doi: 10.1038/nmeth.1288
113. Hodson DJ, Mitchell RK, Johnston N, Thorens B, Ferrer J, Rutter GA (2014) Optical control of beta cell function. Diabet Med 31:6
114. Nauck MA, Homberger E, Siegel EG, Allen RC, Eaton RP, Ebert R, Creutzfeldt W (1986) Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab 63(2):492-498. doi: 10.1210/jcem-63-2-492
115. Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W (1993) Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 91(1):301-307. doi: 10.1172/JCI116186
116. Kjems LL, Holst JJ, Volund A, Madsbad S (2003) The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects. Diabetes 52(2):380-386
117. Meier JJ, Nauck MA (2010) Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function? Diabetes 59(5):1117-1125. doi: 10.2337/db09-1899
118. Muscelli E, Mari A, Casolaro A, Camastra S, Seghieri G, Gastaldelli A, Holst JJ, Ferrannini E (2008) Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients. Diabetes 57(5):1340-1348. doi: 10.2337/db07-1315
119. Knop FK, Aaboe K, Vilsboll T, Volund A, Holst JJ, Krarup T, Madsbad S (2012) Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity. Diabetes Obes Metab 14(6):500-510. doi: 10.1111/j.1463-1326.2011.01549.x
120. Allagnat F, Alonso F, Martin D, Abderrahmani A, Waeber G, Haefliger JA (2008) ICER-1gamma overexpression drives palmitate-mediated connexin36 down-regulation in insulin-secreting cells. J Biol Chem 283(9):5226-5234. doi: 10.1074/jbc.M708181200
121. Haefliger JA, Martin D, Favre D, Petremand Y, Mazzolai L, Abderrahmani A, Meda P, Waeber G, Allagnat F (2013) Reduction of connexin36 content by ICER-1 contributes to insulin-secreting cells apoptosis induced by oxidized LDL particles. PLoS ONE 8(1):e55198. doi: 10.1371/journal.pone.0055198
122. Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD (1987) Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 30(10):763-768
123. Pierce M, Keen H, Bradley C (1995) Risk of diabetes in offspring of parents with non-insulin-dependent diabetes. Diabet Med 12(1):6-13. doi: 10.1111/j.1464-5491.1995.tb02054.x
124. Medici F, Hawa M, Ianari A, Pyke DA, Leslie RD (1999) Concordance rate for type II diabetes mellitus in monozygotic twins: actuarial analysis. Diabetologia 42(2):146-150. doi: 10.1007/s001250051132
125. Rutter GA (2014) Understanding genes identified by genome-wide association studies for type 2 diabetes. Diabet Med. doi: 10.1111/dme.12579
126. McCarthy MI (2010) Genomics, type 2 diabetes, and obesity. N Engl J Med 363(24):2339-2350. doi: 10.1056/NEJMra0906948
127. Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P, Sjogren M, Ling C, Eriksson KF, Lethagen AL, Mancarella R, Berglund G, Tuomi T, Nilsson P, Del Prato S, Groop L (2007) Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 117(8):2155-2163. doi: 10.1172/JCI30706
128. Salonen JT, Uimari P, Aalto JM, Pirskanen M, Kaikkonen J, Todorova B, Hypponen J, Korhonen VP, Asikainen J, Devine C, Tuomainen TP, Luedemann J, Nauck M, Kerner W, Stephens RH, New JP, Ollier WE, Gibson JM, Payton A, Horan MA, Pendleton N, Mahoney W, Meyre D, Delplanque J, Froguel P, Luzzatto O, Yakir B, Darvasi A (2007) Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium. Am J Hum Genet 81(2):338-345. doi: 10.1086/520599
129. Vaxillaire M, Veslot J, Dina C, Proenca C, Cauchi S, Charpentier G, Tichet J, Fumeron F, Marre M, Meyre D, Balkau B, Froguel P (2008) Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. Diabetes 57(1):244-254. doi: 10.2337/db07-0615
130. Palmer ND, Lehtinen AB, Langefeld CD, Campbell JK, Haffner SM, Norris JM, Bergman RN, Goodarzi MO, Rotter JI, Bowden DW (2008) Association of TCF7L2 gene polymorphisms with reduced acute insulin response in Hispanic Americans. J Clin Endocrinol Metab 93(1):304-309. doi: 10.1210/jc.2007-1225
131. Schafer SA, Tschritter O, Machicao F, Thamer C, Stefan N, Gallwitz B, Holst JJ, Dekker JM, t Hart LM, Nijpels G, van Haeften TW, Haring HU, Fritsche A (2007) Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia 50(12):2443-2450. doi: 10.1007/s00125-007-0753-6
132. Pilgaard K, Jensen CB, Schou JH, Lyssenko V, Wegner L, Brons C, Vilsboll T, Hansen T, Madsbad S, Holst JJ, Volund A, Poulsen P, Groop L, Pedersen O, Vaag AA (2009) The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men. Diabetologia 52(7):1298-1307. doi: 10.1007/s00125-009-1307-x
133. da Silva Xavier G, Loder MK, McDonald A, Tarasov AI, Carzaniga R, Kronenberger K, Barg S, Rutter GA (2009) TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells. Diabetes 58(4):894-905. doi: 10.2337/db08-1187
134. Shu L, Sauter NS, Schulthess FT, Matveyenko AV, Oberholzer J, Maedler K (2008) Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets. Diabetes 57(3):645-653. doi: 10.2337/db07-0847
135. da Silva Xavier G, Mondragon A, Sun G, Chen L, McGinty JA, French PM, Rutter GA (2012) Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice. Diabetologia 55(10):2667-2676. doi: 10.1007/s00125-012-2600-7
136. da Silva Xavier G, Mondragon A, Mitchell RK, Hodson DJ, Ferrer J, Thoren B, Chen L, McGinty JA, French PM, Rutter GA (2014) Defective glucose homeostasis in mice inactivated selectively for Tcf7l2 in the adult beta cell with an Ins1-controlled Cre. In: EASD, Vienna. Diabetologia. http://www.easdvirtualmeeting.org/resources/17180 (in press)
137. Boj SF, van Es JH, Huch M, Li VS, Jose A, Hatzis P, Mokry M, Haegebarth A, van den Born M, Chambon P, Voshol P, Dor Y, Cuppen E, Fillat C, Clevers H (2012) Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand. Cell 151(7):1595-1607. doi: 10.1016/j.cell.2012.10.053
138. Shu L, Matveyenko AV, Kerr-Conte J, Cho JH, McIntosh CH, Maedler K (2009) Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Hum Mol Genet 18(13):2388-2399. doi: 10.1093/hmg/ddp178
139. Rosengren AH, Braun M, Mahdi T, Andersson SA, Travers ME, Shigeto M, Zhang E, Almgren P, Ladenvall C, Axelsson AS, Edlund A, Pedersen MG, Jonsson A, Ramracheya R, Tang Y, Walker JN, Barrett A, Johnson PR, Lyssenko V, McCarthy MI, Groop L, Salehi A, Gloyn AL, Renstrom E, Rorsman P, Eliasson L (2012) Reduced insulin exocytosis in human pancreatic beta-cells with gene variants linked to type 2 diabetes. Diabetes 61(7):1726-1733. doi: 10.2337/db11-1516
140. Loder MK, da Silva Xavier G, McDonald A, Rutter GA (2008) TCF7L2 controls insulin gene expression and insulin secretion in mature pancreatic beta-cells. Biochem Soc Trans 36(Pt 3):357-359. doi: 10.1042/BST0360357
141. Zhou Y, Park SY, Su J, Bailey K, Ottosson-Laakso E, Shcherbina L, Oskolkov N, Zhang E, Thevenin T, Fadista J, Bennet H, Vikman P, Wierup N, Fex M, Rung J, Wollheim C, Nobrega M, Renstrom E, Groop L, Hansson O (2014) TCF7L2 is a master regulator of insulin production and processing. Hum Mol Genet. doi: 10.1093/hmg/ddu359
142. 2+)-inhibitable adenylyl cyclase from NCB-20 cells. Proc Natl Acad Sci USA 89(15):6716-6720
143. Yan L, Vatner DE, O'Connor JP, Ivessa A, Ge H, Chen W, Hirotani S, Ishikawa Y, Sadoshima J, Vatner SF (2007) Type 5 adenylyl cyclase disruption increases longevity and protects against stress. Cell 130(2):247-258. doi: 10.1016/j.cell.2007.05.038
144. Holz GG, Leech CA, Chepurny OG (2014) New insights concerning the molecular basis for defective glucoregulation in soluble adenylyl cyclase knockout mice. Biochim Biophys Acta. doi: 10.1016/j.bbadis.2014.06.023
145. Leech CA, Castonguay MA, Habener JF (1999) Expression of adenylyl cyclase subtypes in pancreatic beta-cells. Biochem Biophys Res Commun 254(3):703-706. doi: 10.1006/bbrc.1998.9906
146. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, Gloyn AL, Lindgren CM, Magi R, Morris AP, Randall J, Johnson T, Elliott P, Rybin D, Thorleifsson G, Steinthorsdottir V, Henneman P, Grallert H, Dehghan A, Hottenga JJ, Franklin CS, Navarro P, Song K, Goel A, Perry JR, Egan JM, Lajunen T, Grarup N, Sparso T, Doney A, Voight BF, Stringham HM, Li M, Kanoni S, Shrader P, Cavalcanti-Proenca C, Kumari M, Qi L, Timpson NJ, Gieger C, Zabena C, Rocheleau G, Ingelsson E, An P, O'Connell J, Luan J, Elliott A, McCarroll SA, Payne F, Roccasecca RM, Pattou F, Sethupathy P, Ardlie K, Ariyurek Y, Balkau B, Barter P, Beilby JP, Ben-Shlomo Y, Benediktsson R, Bennett AJ, Bergmann S, Bochud M, Boerwinkle E, Bonnefond A, Bonnycastle LL, Borch-Johnsen K, Bottcher Y, Brunner E, Bumpstead SJ, Charpentier G, Chen YD, Chines P, Clarke R, Coin LJ, Cooper MN, Cornelis M, Crawford G, Crisponi L, Day IN, de Geus EJ, Delplanque J, Dina C, Erdos MR, Fedson AC, Fischer-Rosinsky A, Forouhi NG, Fox CS, Frants R, Franzosi MG, Galan P, Goodarzi MO, Graessler J, Groves CJ, Grundy S, Gwilliam R, Gyllensten U, Hadjadj S, Hallmans G, Hammond N, Han X, Hartikainen AL, Hassanali N, Hayward C, Heath SC, Hercberg S, Herder C, Hicks AA, Hillman DR, Hingorani AD, Hofman A, Hui J, Hung J, Isomaa B, Johnson PR, Jorgensen T, Jula A, Kaakinen M, Kaprio J, Kesaniemi YA, Kivimaki M, Knight B, Koskinen S, Kovacs P, Kyvik KO, Lathrop GM, Lawlor DA, Le Bacquer O, Lecoeur C, Li Y, Lyssenko V, Mahley R, Mangino M, Manning AK, Martinez-Larrad MT, McAteer JB, McCulloch LJ, McPherson R, Meisinger C, Melzer D, Meyre D, Mitchell BD, Morken MA, Mukherjee S, Naitza S, Narisu N, Neville MJ, Oostra BA, Orru M, Pakyz R, Palmer CN, Paolisso G, Pattaro C, Pearson D, Peden JF, Pedersen NL, Perola M, Pfeiffer AF, Pichler I, Polasek O, Posthuma D, Potter SC, Pouta A, Province MA, Psaty BM, Rathmann W, Rayner NW, Rice K, Ripatti S, Rivadeneira F, Roden M, Rolandsson O, Sandbaek A, Sandhu M, Sanna S, Sayer AA, Scheet P, Scott LJ, Seedorf U, Sharp SJ, Shields B, Sigurethsson G, Sijbrands EJ, Silveira A, Simpson L, Singleton A, Smith NL, Sovio U, Swift A, Syddall H, Syvanen AC, Tanaka T, Thorand B, Tichet J, Tonjes A, Tuomi T, Uitterlinden AG, van Dijk KW, van Hoek M, Varma D, Visvikis-Siest S, Vitart V, Vogelzangs N, Waeber G, Wagner PJ, Walley A, Walters GB, Ward KL, Watkins H, Weedon MN, Wild SH, Willemsen G, Witteman JC, Yarnell JW, Zeggini E, Zelenika D, Zethelius B, Zhai G, Zhao JH, Zillikens MC, Borecki IB, Loos RJ, Meneton P, Magnusson PK, Nathan DM, Williams GH, Hattersley AT, Silander K, Salomaa V, Smith GD, Bornstein SR, Schwarz P, Spranger J, Karpe F, Shuldiner AR, Cooper C, Dedoussis GV, Serrano-Rios M, Morris AD, Lind L, Palmer LJ, Hu FB, Franks PW, Ebrahim S, Marmot M, Kao WH, Pankow JS, Sampson MJ, Kuusisto J, Laakso M, Hansen T, Pedersen O, Pramstaller PP, Wichmann HE, Illig T, Rudan I, Wright AF, Stumvoll M, Campbell H, Wilson JF, Bergman RN, Buchanan TA, Collins FS, Mohlke KL, Tuomilehto J, Valle TT, Altshuler D, Rotter JI, Siscovick DS, Penninx BW, Boomsma DI, Deloukas P, Spector TD, Frayling TM, Ferrucci L, Kong A, Thorsteinsdottir U, Stefansson K, van Duijn CM, Aulchenko YS, Cao A, Scuteri A, Schlessinger D, Uda M, Ruokonen A, Jarvelin MR, Waterworth DM, Vollenweider P, Peltonen L, Mooser V, Abecasis GR, Wareham NJ, Sladek R, Froguel P, Watanabe RM, Meigs JB, Groop L, Boehnke M, McCarthy MI, Florez JC, Barroso I (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42(2):105-116. doi: 10.1038/ng.520
147. Rees SD, Hydrie MZ, O'Hare JP, Kumar S, Shera AS, Basit A, Barnett AH, Kelly MA (2011) Effects of 16 genetic variants on fasting glucose and type 2 diabetes in South Asians: ADCY5 and GLIS3 variants may predispose to type 2 diabetes. PLoS ONE 6(9):e24710. doi: 10.1371/journal.pone.0024710
148. Hodson DJ, Mitchell RK, Marselli L, Pullen TJ, Gimeno Brias S, Semplici F, Everett KL, Cooper DMF, Bugliani M, Marchetti P, Lavallard V, Bosco D, Piemonti L, Johnson PR, Hughes SJ, Li D, Li WH, Shapiro AMJ, Rutter GA (2014) ADCY5 couples glucose to insulin secretion in human islets Diabetes. (in press)
149. Wagner R, Dudziak K, Herzberg-Schafer SA, Machicao F, Stefan N, Staiger H, Haring HU, Fritsche A (2011) Glucose-raising genetic variants in MADD and ADCY5 impair conversion of proinsulin to insulin. PLoS ONE 6(8):e23639. doi: 10.1371/journal.pone.0023639
150. Mears D, Sheppard NF Jr, Atwater I, Rojas E (1995) Magnitude and modulation of pancreatic beta-cell gap junction electrical conductance in situ. J Membr Biol 146(2):163-176
151. Lemaire K, Ravier MA, Schraenen A, Creemers JW, Van de Plas R, Granvik M, Van Lommel L, Waelkens E, Chimienti F, Rutter GA, Gilon P, in't Veld PA, Schuit FC (2009) Insulin crystallization depends on zinc transporter ZnT8 expression, but is not required for normal glucose homeostasis in mice. Proc Natl Acad Sci USA 106(35):14872-14877. doi: 10.1073/pnas.0906587106
152. Nicolson TJ, Bellomo EA, Wijesekara N, Loder MK, Baldwin JM, Gyulkhandanyan AV, Koshkin V, Tarasov AI, Carzaniga R, Kronenberger K, Taneja TK, da Silva Xavier G, Libert S, Froguel P, Scharfmann R, Stetsyuk V, Ravassard P, Parker H, Gribble FM, Reimann F, Sladek R, Hughes SJ, Johnson PR, Masseboeuf M, Burcelin R, Baldwin SA, Liu M, Lara-Lemus R, Arvan P, Schuit FC, Wheeler MB, Chimienti F, Rutter GA (2009) Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes 58(9):2070-2083. doi: 10.2337/db09-0551
153. Wijesekara N, Dai FF, Hardy AB, Giglou PR, Bhattacharjee A, Koshkin V, Chimienti F, Gaisano HY, Rutter GA, Wheeler MB (2010) Beta cell-specific ZnT8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion. Diabetologia 53(8):1656-1668. doi: 10.1007/s00125-010-1733-9
154. Rutter GA (2010) Think zinc: new roles for zinc in the control of insulin secretion. Islets 2(1):49-50. doi: 10.4161/isl.2.1.10259
155. Tamaki M, Fujitani Y, Hara A, Uchida T, Tamura Y, Takeno K, Kawaguchi M, Watanabe T, Ogihara T, Fukunaka A, Shimizu T, Mita T, Kanazawa A, Imaizumi MO, Abe T, Kiyonari H, Hojyo S, Fukada T, Kawauchi T, Nagamatsu S, Hirano T, Kawamori R, Watada H (2013) The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance. J Clin Invest 123(10):4513-4524. doi: 10.1172/JCI68807
156. Flannick J, Thorleifsson G, Beer NL, Jacobs SB, Grarup N, Burtt NP, Mahajan A, Fuchsberger C, Atzmon G, Benediktsson R, Blangero J, Bowden DW, Brandslund I, Brosnan J, Burslem F, Chambers J, Cho YS, Christensen C, Douglas DA, Duggirala R, Dymek Z, Farjoun Y, Fennell T, Fontanillas P, Forsen T, Gabriel S, Glaser B, Gudbjartsson DF, Hanis C, Hansen T, Hreidarsson AB, Hveem K, Ingelsson E, Isomaa B, Johansson S, Jorgensen T, Jorgensen ME, Kathiresan S, Kong A, Kooner J, Kravic J, Laakso M, Lee JY, Lind L, Lindgren CM, Linneberg A, Masson G, Meitinger T, Mohlke KL, Molven A, Morris AP, Potluri S, Rauramaa R, Ribel-Madsen R, Richard AM, Rolph T, Salomaa V, Segre AV, Skarstrand H, Steinthorsdottir V, Stringham HM, Sulem P, Tai ES, Teo YY, Teslovich T, Thorsteinsdottir U, Trimmer JK, Tuomi T, Tuomilehto J, Vaziri-Sani F, Voight BF, Wilson JG, Boehnke M, McCarthy MI, Njolstad PR, Pedersen O, Groop L, Cox DR, Stefansson K, Altshuler D (2014) Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nat Genet 46(4):357-363. doi: 10.1038/ng.2915
157. 2+ in pancreatic beta cells. Diabetologia. doi: 10.1007/s00125-014-3266-0
158. Sun Z, Zhang DQ, McMahon DG (2009) Zinc modulation of hemi-gap-junction channel currents in retinal horizontal cells. J Neurophysiol 101(4):1774-1780. doi: 10.1152/jn.90581.2008
159. Lurtz MM, Louis CF (2007) Intracellular calcium regulation of connexin43. Am J Physiol Cell Physiol 293(6):C1806-C1813. doi: 10.1152/ajpcell.00630.2006
160. 2+ oscillations evaluates Cx36-dependent coupling. PLoS ONE 7(7):e41535. doi: 10.1371/journal.pone.0041535
161. Amisten S, Salehi A, Rorsman P, Jones PM, Persaud SJ (2013) An atlas and functional analysis of G-protein coupled receptors in human islets of Langerhans. Pharmacol Ther 139(3):359-391. doi: 10.1016/j.pharmthera.2013.05.004
162. Zhou K, Pearson ER (2013) Insights from genome-wide association studies of drug response. Annu Rev Pharmacol Toxicol 53:299-310. doi: 10.1146/annurev-pharmtox-011112-140237
163. Meda P, Michaels RL, Halban PA, Orci L, Sheridan JD (1983) In vivo modulation of gap junctions and dye coupling between B-cells of the intact pancreatic islet. Diabetes 32(9):858-868
164. Donnelly LA, Doney ASF, Hattersley AT, Morris AD, Pearson ER (2006) The effect of obesity on glycaemic response to metformin or sulphonylureas in type 2 diabetes. Diabet Med 23(2):128-133. doi: 10.1111/j.1464-5491.2005.01755.x
165. Kim S, Putrino D, Ghosh S, Brown EN (2011) A Granger causality measure for point process models of ensemble neural spiking activity. PLoS Comput Biol 7(3):e1001110. doi: 10.1371/journal.pcbi.1001110.